GlassScriptPhysician profile
Gregory L Eads
NPI 1609803006
$19,296.76
in general payments reported to CMS, 2019-2025
27 companies · $281 in 2025
The $281 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $6,044 · 2021: $1,012 · 2022: $899 · 2023: $335 · 2024: $461 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $971 · Education: $83.27 · Travel and Lodging: $23.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $971.05 |
| Education | $83.27 |
| Travel and Lodging | $23.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $15,040.20 | 2019-2025 | |
| Boston Scientific Corporation | $816.79 | 2019-2024 | Advantage System |
| Pfizer INC. | $631.22 | 2019-2024 | |
| Astellas Pharma US INC | $481.51 | 2019-2024 | Veozah, Myrbetriq |
| Abbvie INC. | $386.11 | 2019-2025 | Liletta, Lo Loestrin Fe |
| Inari Medical, INC. | $293.98 | 2021 | |
| Amgen INC. | $186.98 | 2019-2025 | Evenity, Prolia |
| Sumitomo Pharma America, INC. | $175.77 | 2023-2025 | Myfembree |
| Millicent US INC | $166.38 | 2019-2025 | Intrarosa, Femring, Femlyv |
| Novo Nordisk INC | $131.94 | 2019-2022 | |
| Medtronic, INC. | $121.19 | 2022-2024 | V-Loc 180 |
| Myovant Sciences INC. | $111.27 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $103.71 | 2023-2025 | |
| Coopersurgical, INC. | $99.83 | 2024 | Advincula Delineator Uterine Manipulator, Wallach Cryosurgical Equipment |
| Therapeuticsmd, INC. | $86.06 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $68.83 | 2019-2020 | |
| Avion Pharmaceuticals | $61.33 | 2020-2022 | |
| Exeltis, USA INC. | $60.87 | 2023-2025 | Slynd |
| Ascend Therapeutics US, LLC | $57.85 | 2020-2024 | |
| Lilly USA, LLC | $46.18 | 2024 | Zepbound |
| Exact Sciences Corporation | $42.77 | 2024-2025 | Cologuard Collection Kit |
| Caldera Medical, INC | $31.91 | 2021 | |
| Vertical Pharmaceuticals, LLC | $29.51 | 2019-2020 | |
| Urovant Sciences INC | $19.71 | 2022 | |
| Biom'Up Sa | $19.03 | 2019 | |
| Allergan, INC. | $13.85 | 2019 | |
| Minerva Surgical, INC | $11.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Eads listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.